Volunteers taking part in third stage of Russian COVID-19 trials won’t be hospitalized
Volunteers taking part in the third stage of the clinical trials of the Russian COVID-19 vaccine developed by the N. F. Gamaleya Federal Research Center for Epidemiology and Microbiology will not be hospitalized, head of the center Alexander Ginzberg said, TASS reports.
"Of course, the volunteers won’t be hospitalized beforehand. All of them will come and go from their homes," he said.
Ginzburg added that the volunteers would donate blood for testing on the first day of the trials. "This is done so that there will be a starting point, so that we can compare a rise in antibodies," he noted. The next blood test will be made in 21 days after the first vaccine shot and in 21 days after the second one.
The researcher said that so far, there is no final protocol on clinical trials after the vaccine’s registration, however, he assumed that the trials would be less rigorous.